I-Mab(IMAB) - 2024 Q2 - Earnings Call Transcript

I-MAB Biopharma (NASDAQ:IMAB) Q2 2024 Earnings Conference Call August 28, 2024 8:00 AM ET Company Participants Sean Fu - Chief Executive Officer (interim) Phillip Dennis - Chief Medical Officer Joseph Skelton - Chief Financial Officer Tyler Ehler - Vice President, Investor Relations Conference Call Participants Joe Catanzaro - Piper Sandler Unknown Analyst - Jefferies Andres Maldonado - HC Wainwright Operator Greetings. Welcome to I-MAB Biopharma’s first half 2024 financial results and corporate update conf ...